{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:25:29Z","timestamp":1791084329567,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK122364"],"award-info":[{"award-number":["R01DK122364"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R01AT012053"],"award-info":[{"award-number":["R01AT012053"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cannabis use is common in inflammatory bowel disease (IBD). Recent studies demonstrated that use of cannabis may relieve symptoms; however, it is still unclear how safe cannabis and its derivatives are for IBD patients. We performed this study to evaluate the impact of cannabis use on several key clinical outcomes in IBD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective study using the TriNetX Diamond Network. Cannabis use and noncannabis use subcohorts were identified for 3 patient groups: (1) IBD, (2) Crohn\u2019s disease (CD), and (3) ulcerative colitis (UC). Baseline differences between subcohorts for each group were controlled by propensity score matching. In each group, we compared relative incidence of emergency department (ED) visits, hospitalization, corticosteroid use, opioid use, IBD-related surgery, and death between cannabis users and noncannabis users.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Inflammatory bowel disease cannabis users demonstrated an increased risk for corticosteroid use (risk ratios [R],1.095; 95% CI, 1.021-1.174; P = .011), ED visits (RR, 2.143; 95% CI, 2.034-2.257; P &amp;lt; .001), hospitalizations (RR, 1.925; 95% CI, 1.783-2.079; P &amp;lt; .001) and opioid use (RR, 1.35; 95% CI, 1.14-1.6); P &amp;lt; .001), but not an increased risk of IBD-related surgery or death. The CD and UC groups exhibited similar outcomes, except only CD demonstrated an increased risk for corticosteroid and opioid use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cannabis use in IBD patients is associated with several poor clinical outcomes, including increased risk of corticosteroid and opioid use, ED visits and hospitalization, though not IBD-related surgery or death. It is not clear what drives these risks or whether they are directly related to IBD-associated disease activity or other factors. Further prospective studies are warranted to more carefully investigate these relationships.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izad151","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T16:39:04Z","timestamp":1689266344000},"page":"1055-1061","source":"Crossref","is-referenced-by-count":21,"title":["The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study"],"prefix":"10.1093","volume":"30","author":[{"given":"Danny","family":"Glickman","sequence":"first","affiliation":[{"name":"Penn State College of Medicine , Hershey, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Dalessio","sequence":"additional","affiliation":[{"name":"Penn State College of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology , Hershey, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley M","family":"Raup-Konsavage","sequence":"additional","affiliation":[{"name":"Penn State College of Medicine, Department of Pharmacology , Hershey, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent E","family":"Vrana","sequence":"additional","affiliation":[{"name":"Penn State College of Medicine, Department of Pharmacology , Hershey, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8976-5015","authenticated-orcid":false,"given":"Matthew D","family":"Coates","sequence":"additional","affiliation":[{"name":"Penn State College of Medicine, Department of Pharmacology , Hershey, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"issue":"4","key":"2024070305515788900_CIT0001","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ibd\/izx100","article-title":"Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part I","volume":"24","author":"Knowles","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"2024070305515788900_CIT0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ecco-jcc\/jjw145","article-title":"Patient-reported outcomes in a French nationwide survey of inflammatory bowel disease patients","volume":"11","author":"Williet","year":"2017","journal-title":"J Crohns Colitis."},{"key":"2024070305515788900_CIT0003","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/JIR.S165330","article-title":"Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives","volume":"11","author":"Rawla","year":"2018","journal-title":"J Inflamm Res."},{"issue":"1","key":"2024070305515788900_CIT0004","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12325-019-01151-w","article-title":"Fatigue in inflammatory bowel diseases: etiologies and management","volume":"37","author":"Nocerino","year":"2020","journal-title":"Adv Ther."},{"issue":"1","key":"2024070305515788900_CIT0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12876-019-0963-7","article-title":"Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort","volume":"19","author":"Perler","year":"2019","journal-title":"BMC Gastroenterol."},{"issue":"10","key":"2024070305515788900_CIT0006","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/nu12102975","article-title":"Inflammatory bowel disease: are symptoms and diet linked","volume":"12","author":"Morton","year":"2020","journal-title":"Nutrients."},{"key":"2024070305515788900_CIT0007","doi-asserted-by":"crossref","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai","year":"2021","journal-title":"Front Med (Lausanne)."},{"issue":"4","key":"2024070305515788900_CIT0008","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/can.2020.0155","article-title":"Symptoms and extraintestinal manifestations in active cannabis users with inflammatory bowel disease","volume":"7","author":"Coates","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"issue":"11","key":"2024070305515788900_CIT0009","first-page":"668","article-title":"Therapeutic use of cannabis in inflammatory bowel disease","volume":"12","author":"Ahmed","year":"2016","journal-title":"Gastroenterol Hepatol (N Y)."},{"issue":"6426","key":"2024070305515788900_CIT0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/363215a0","article-title":"Early medical use of cannabis","volume":"363","author":"Zlas","year":"1993","journal-title":"Nature."},{"issue":"7303","key":"2024070305515788900_CIT0011","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/bmj.323.7303.16","article-title":"Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review","volume":"323","author":"Tramer","year":"2001","journal-title":"BMJ."},{"issue":"7","key":"2024070305515788900_CIT0012","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jnnp-2017-317168","article-title":"Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence","volume":"89","author":"Stockings","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"3-4","key":"2024070305515788900_CIT0013","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000521683","article-title":"Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals","volume":"107","author":"Legare","year":"2022","journal-title":"Pharmacology."},{"issue":"3","key":"2024070305515788900_CIT0014","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/ibd\/izy319","article-title":"The role of cannabis in the management of inflammatory bowel disease: a review of clinical, scientific, and regulatory information","volume":"25","author":"Swaminath","year":"2019","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2024070305515788900_CIT0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000517425","article-title":"Cannabis and cannabis derivatives for abdominal pain management in inflammatory bowel disease","volume":"4","author":"Bogale","year":"2021","journal-title":"Med Cannabis Cannabinoids."},{"issue":"8","key":"2024070305515788900_CIT0016","first-page":"455","article-title":"Treatment of Crohn\u2019s disease with cannabis: an observational study","volume":"13","author":"Naftali","year":"2011","journal-title":"Isr Med Assoc J."},{"issue":"32","key":"2024070305515788900_CIT0017","doi-asserted-by":"crossref","first-page":"e16551","DOI":"10.1097\/MD.0000000000016551","article-title":"Association between cannabis use and complications related to ulcerative colitis in hospitalized patients: A propensity matched retrospective cohort study","volume":"98","author":"Mbachi","year":"2019","journal-title":"Medicine (Baltim)."},{"issue":"10","key":"2024070305515788900_CIT0018","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s10620-019-05556-z","article-title":"Association between cannabis use and complications related to Crohn\u2019s disease: a retrospective cohort study","volume":"64","author":"Mbachi","year":"2019","journal-title":"Dig Dis Sci."},{"issue":"7","key":"2024070305515788900_CIT0019","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1007\/s10620-016-4090-9","article-title":"Cannabis abuse is increasing and associated with increased emergency department utilization in gastroenterology patients","volume":"61","author":"Gubatan","year":"2016","journal-title":"Dig Dis Sci."},{"issue":"3","key":"2024070305515788900_CIT0020","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.MIB.0000440982.79036.d6","article-title":"Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn\u2019s disease","volume":"20","author":"Storr","year":"2014","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2024070305515788900_CIT0021","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ibd\/izaa104","article-title":"Preadmission cannabis use is positively correlated with inpatient opioid dose exposure in hospitalized patients with inflammatory bowel diseases","volume":"27","author":"Dalal","year":"2021","journal-title":"Inflamm Bowel Dis."},{"issue":"8","key":"2024070305515788900_CIT0022","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.addbeh.2010.03.019","article-title":"Systematic review of prospective studies investigating \u201cremission\u201d from amphetamine, cannabis, cocaine or opioid dependence","volume":"35","author":"Calabria","year":"2010","journal-title":"Addict Behav."},{"issue":"8","key":"2024070305515788900_CIT0023","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1176\/appi.ajp.2016.14050637","article-title":"Cannabis, psychosis, and mortality: a cohort study of 50,373 Swedish men","volume":"173","author":"Manrique-Garcia","year":"2016","journal-title":"Am J Psychiatry."},{"key":"2024070305515788900_CIT0024","doi-asserted-by":"crossref","first-page":"114741","DOI":"10.1016\/j.psychres.2022.114741","article-title":"Mortality risk for individuals with cannabis use disorders in relation to alcohol use disorders: Results of a follow-up study","volume":"316","author":"Pavarin","year":"2022","journal-title":"Psychiatry Res."},{"issue":"4","key":"2024070305515788900_CIT0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2105\/AJPH.87.4.585","article-title":"Marijuana use and mortality","volume":"87","author":"Sidney","year":"1997","journal-title":"Am J Public Health."},{"issue":"8","key":"2024070305515788900_CIT0026","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/15563650.2018.1548708","article-title":"Acute cannabis toxicity","volume":"57","author":"Noble","year":"2019","journal-title":"Clin Toxicol (Phila)."},{"issue":"1","key":"2024070305515788900_CIT0027","doi-asserted-by":"crossref","first-page":"e001216","DOI":"10.1136\/bmjresp-2022-001216","article-title":"Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study","volume":"9","author":"Vozoris","year":"2022","journal-title":"BMJ Open Respir Res."},{"issue":"3","key":"2024070305515788900_CIT0028","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1097\/MJT.0000000000000655","article-title":"Emergency department treatment of cannabinoid hyperemesis syndrome: a review","volume":"25","author":"Khattar","year":"2018","journal-title":"Am J Ther."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izad151\/51112233\/izad151.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/7\/1055\/58282352\/izad151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/7\/1055\/58282352\/izad151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T01:54:17Z","timestamp":1719971657000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/30\/7\/1055\/7242562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,8,14]]},"published-print":{"date-parts":[[2024,7,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izad151","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7,1]]},"published":{"date-parts":[[2023,8,14]]}}}